| Product Name | MF | CAS | Details |
|---|
| Topoisomerase II inhibitor 7 | C32H28BrN5O5S | 2697171-03-0 | Details |
| (-)-15-Deoxyspergualin | 89149-10-0 | Details |
| (R,R)-Reboxetine mesylate | C20H27NO6S | 105017-39-8 | Details |
| ML-077 | C17H16N4OS2 | 1135304-61-8 | Details |
| Cyclic-di-GMP diammonium | C20H27N11O14P2 | 609343-82-0 | Details |
| KRAS G12C inhibitor 37 | C35H39F3N8O2 | 2241720-04-5 | Details |
| Antibacterial agent 64 | C29H20ClN3O6S2 | 618865-52-4 | Details |
| N 0840 | C11H15N5 | 109292-91-3 | Details |
| P-CAB agent 2 hydrochloride | C22H26ClFN2O4S | 2209911-80-6 | Details |
| PI3K/mTOR Inhibitor-13 | C20H13F2N5O3S | 1621718-37-3 | Details |
| Antituberculosis agent-6 | C27H20F2N2O3 | 2874263-72-4 | Details |
| Phosphoglycolohydroxamic acid | C2H6NO6P | 51528-59-7 | Details |
| Carbonic anhydrase inhibitor 12 | C27H22BrN5O5S2 | 2883451-38-3 | Details |
| Eleven-Nineteen-Leukemia Protein IN-3 | C28H27N5O2 | 2894121-83-4 | Details |
| Tubulin polymerization-IN-40 | C24H22FNO5 | 2921670-94-0 | Details |
| Sodium ((2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl diphosphate | C10H16N5NaO11P2 | 9652-27-6 | Details |
| D,L-erythro-PDMP hydrochloride | C23H39ClN2O3 | 80943-40-4 | Details |
| ST101036 | C18H21F3N4 | 1018143-39-9 | Details |
| KRAS G12C inhibitor 39 | C37H43N9O2 | 2326522-16-9 | Details |
| α-Synuclein inhibitor 8 | C24H20N2O6 | 2883627-64-1 | Details |
| PUN-96956 | C21H33ClN2 | 1144496-95-6 | Details |
| Antiproliferative agent-20 | C23H18N2O6 | 1344715-94-1 | Details |
| Mitochondria degrader-1 | C33H49ClFN7O8S | 2241669-05-4 | Details |
| Teslexivir hydrochloride | C35H37BrClN3O4 | 1075281-70-7 | Details |
| DYRKs-IN-1 hydrochloride | C30H31Cl2N7O4 | 1386980-55-7 | Details |
| Antiproliferative agent-17 | C26H28N2OS | 2882206-08-6 | Details |
| 3β-Hydroxy-hop-22(29)-ene | C30H50O | 58801-23-3 | Details |
| PI3K/mTOR Inhibitor-12 | C27H27F2N9O4S | 2891692-83-2 | Details |
| ADRA1D receptor antagonist 1 free base | C15H13ClN4O | 1191908-24-3 | Details |
| Antituberculosis agent-8 | C25H19F3N2O3 | 2874263-74-6 | Details |
| KRAS G12C inhibitor 35 | C31H27ClF2N6O3 | 2650550-87-9 | Details |
| SRT 1720 dihydrochloride | C25H24ClN7OS | 2468639-77-0 | Details |
| PI3K/Akt/CREB activator 1 | C19H15F4NO3 | 2708177-73-3 | Details |
| Topoisomerase IV inhibitor 1 | C34H32FN7O6S | 2883403-42-5 | Details |
| Eleven-Nineteen-Leukemia Protein IN-1 | C27H33N7O2 | 2894121-68-5 | Details |
| MRS2768 tetrasodium salt | 2567869-47-8 | Details |
| Mtb-cyt-bd oxidase-IN-6 | C20H27NO | 1246461-10-8 | Details |
| SARS-CoV-2 3CLpro-IN-5 | C22H26ClF2N5O4 | 2913186-57-7 | Details |
| ZINC09410451 | C24H27ClN4O3 | 1093065-66-7 | Details |
| ZINC32540717 | C23H26N4O3 | 1010869-76-7 | Details |
| Difluorocyclooctyne-CH2-COOH | C10H12F2O2 | 1047997-31-8 | Details |
| E09241 | C11H9ClN2O2 | 1043110-13-9 | Details |
| NK1 receptor antagonist 2 | C31H35F7N4O2 | 579475-17-5 | Details |
| Antileishmanial agent-13 | C17H10BrClN4O | 853725-86-7 | Details |
| Tilpisertib fosmecarbil | C35H36ClN8O7P | 2567459-64-5 | Details |
| Ladostigil hydrochloride | C16H21ClN2O2 | 209394-18-3 | Details |
| Topoisomerase IV inhibitor 2 | C33H30FN7O6S | 2883403-36-7 | Details |
| β2AR/M-receptor agonist-2 | C36H49ClN4O7S | 1017857-38-3 | Details |
| Glucocorticoid receptor modulator 1 | C24H23ClN2O4S | 2868357-11-1 | Details |
| KYN-101 | C22H19FN6 | 2247950-73-6 | Details |
| VU0621623 | C20H21F2N5O3S | 1115899-15-4 | Details |
| 673-A | C15H13NO | 109437-62-9 | Details |
| Asterriquinol D dimethyl ether | C26H24N2O4 | 287117-66-2 | Details |
| MAO-B ligand-1 | C19H19N5O4S | 1010879-39-6 | Details |
| KRAS G12C inhibitor 40 | C34H36ClFN10O2 | 2660014-14-0 | Details |
| 6-trans-12-epi-Leukotriene B4 | C20H32O4 | 71548-19-1 | Details |
| DSP-1053 benzenesulfonate | C32H38BrNO7S | 1176326-78-5 | Details |
| PF-06815345 hydrochloride | C27H30Cl2FN9O4 | 2334434-49-8 | Details |
| Dihydro-β-erythroidine | C16H21N1O3 | 23255-54-1 | Details |
| CB-892 | C15H14N2O4 | 1032336-22-3 | Details |
| Eleven-Nineteen-Leukemia Protein IN-2 | C22H23N5O2 | 2894121-78-7 | Details |
| BRM/BRG1 ATP Inhibitor-3 | C26H25N5O2S2 | 2368901-31-7 | Details |
| SARS-CoV-2 3CLpro-IN-7 | C24H17ClN2O6 | 1164478-67-4 | Details |
| BRM/BRG1 ATP Inhibitor-4 | C25H32N6O3S | 2422030-94-0 | Details |
| Menin-MLL inhibitor 26 | C27H29F3N6O3S | 2440018-29-9 | Details |
| Velagliflozin proline hydrate | C28H34N2O7 | 1661838-94-3 | Details |
| Loxoprofenol-SRS tromethamine | C19H31NO6 | 2582872-01-1 | Details |
| KRAS G12C inhibitor 45 | C32H33F2N5O5S | 2670380-74-0 | Details |
| Larotinib mesylate hydrate | C25H30ClFN4O7S | 2097129-93-4 | Details |
| LC kinetic stabilizer-2 | C28H31N3O3 | 2495750-20-2 | Details |
| Lagociclovir valactate | C18H25FN6O6 | 1001670-19-4 | Details |
| 5-Iminodaunorubicin hydrochloride | C27H31ClN2O9 | 67324-99-6 | Details |
| P2X7 receptor antagonist-3 | C17H12ClF3N6O | 1627900-92-8 | Details |
| Anti-inflammatory agent 33 | C22H15N3O5S | 2816993-09-4 | Details |
| Neuroinflammatory-IN-3 | C19H19ClO3 | 1202404-23-6 | Details |
| S1P5 receptor agonist-1 | C20H24F3NO3 | 2373330-78-8 | Details |
| Hsp90-IN-17 hydrochloride | C21H21ClN4O7 | 1253584-63-2 | Details |
| Antibacterial agent 124 | C16H17ClFN3O2 | 2304448-00-6 | Details |
| KRAS G12D inhibitor 10 | C33H41ClN8O2 | 2648551-54-4 | Details |
| RORγt inverse agonist 26 | C27H21F7N2O5S | 2738333-10-1 | Details |
| Cathepsin K inhibitor 3 | C30H31FN4O4S | 1694638-70-4 | Details |
| Cap-dependent endonuclease-IN-7 | C36H28FN3O7S | 2485715-97-5 | Details |
| 3-Chlorogentisyl alcohol | C7H7ClO3 | 32744-80-2 | Details |
| KRAS G12C inhibitor 41 | C36H37ClFN9O2 | 2660014-65-1 | Details |
| LC kinetic stabilizer-1 | C27H31N5O3 | 2495750-19-9 | Details |
| LDC4297 hydrochloride | C23H29ClN8O | 2319747-14-1 | Details |
| Antiarrhythmic agent-1 | C25H27N3O4S | 136081-07-7 | Details |
| Atorvastatin hemicalcium trihydrate | C33H39CaFN2O6 | 344920-08-7 | Details |
| Metallo-β-lactamase-IN-9 | C13H12N6O3S | 1802363-75-2 | Details |
| CypD-IN-29 | C26H20FN5O2S | 1115335-95-9 | Details |
| COR167 | C28H38N2O2 | 1048038-90-9 | Details |
| SARS-CoV-2 3CLpro-IN-6 | C22H15NO7 | 302821-53-0 | Details |
| KRAS G12C inhibitor 20 | C33H37ClFN7O3 | 2640858-10-0 | Details |
| Enpp/Carbonic?anhydrase-IN-2 | C23H24FNO4S | 2883495-39-2 | Details |
| Antibacterial agent 19 | C16H16F2N2O4 | 79660-59-6 | Details |
| KRAS G12C inhibitor 32 | C29H30Cl3FN6O3 | 2756739-00-9 | Details |
| (S)-LY3177833 hydrate | C16H14FN5O2 | 2733342-93-1 | Details |
| (D-Met2,Pro5)-Enkephalinamide | C30H40N6O6S | 63307-63-1 | Details |
| (+)-Dihydrocalanolide A | C22H28O5 | 183904-53-2 | Details |
| ATM-3507 trihydrochloride | C37H47ClFN5O2 | 2438679-30-0 | Details |
| Product Total： Product Page： | ||||
| 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 | ||||